Legal Representation
Attorney
Joyce von Natzmer
USPTO Deadlines
Next Deadline
307 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161206)
Due Date
December 06, 2026
Grace Period Ends
June 06, 2027
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 6, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Sep 30, 2023 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Sep 30, 2023 | 8.PR | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | Loading... |
| Sep 22, 2023 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Jun 2, 2023 | PRA8 | O | POST REGISTRATION ACTION MAILED - SEC. 8 | Loading... |
| Jun 2, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 2, 2022 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Dec 6, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 31, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 6, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 31, 2016 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Oct 11, 2016 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Oct 30, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 11, 2016 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 23, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 28, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 28, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 8, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 20, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 13, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 5, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 5, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 28, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 15, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 19, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 11, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 10, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
[ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; vaccines; pharmaceutical preparations for skin care ]
Class 042
Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development
Class 044
Medical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins
Classification
International Classes
005
042
044